# Nevro

> Analysis by Optimly for Optimly AI Visibility, in the Optimly AI Brand Index. Last analyzed August 9, 2026.

> Nevro provides innovative solutions for chronic pain management, primarily through its 10 kHz Therapy and HFX spinal cord stimulation (SCS) system. The HFX system offers individualized relief and has FDA approval for specific indications such as painful diabetic neuropathy (PDN) and non-surgical back pain (NSBP), aiming to deliver comprehensive, long-term pain relief.

- Business Profile: https://optimly.ai/brand/nevro
- Publisher: Optimly (https://optimly.ai)
- Dataset: Optimly AI Brand Index (https://optimly.ai/brand)
- Official website: https://nevro.com/
- Logo: https://logo.clearbit.com/nevro.com
- Slug: nevro
- Brand Authority Index tier: Low Visibility
- Archetype: Incumbent
- Category: Medical Devices
- Last Analyzed: August 9, 2026

## Buyer Intent Signals
Problems: Traditional Pain Management: Utilizing pharmacological interventions (e.g., opioids, NSAIDs), physical therapy, occupational therapy, and cognitive-behavioral therapy for chronic pain. | Living with Chronic Pain: Choosing not to pursue advanced interventional treatments, continuing to manage pain with existing methods or enduring chronic discomfort.
Solutions: Nevro 10 kHz Therapy | HFX spinal cord stimulation PDN | Alternative SCS Systems: Using spinal cord stimulation systems from competitors such as Medtronic, Abbott, or Boston Scientific, which may offer different stimulation paradigms or features. | Other Interventional Pain Procedures: Procedures like nerve blocks, radiofrequency ablation, or intrathecal drug delivery systems.
Comparisons: Alternatives to spinal cord stimulation for chronic pain
---
## Full Details / RAG Data
### Overview
Nevro has a Business Profile in the Optimly AI Brand Index.
Nevro provides innovative solutions for chronic pain management, primarily through its 10 kHz Therapy and HFX spinal cord stimulation (SCS) system. The HFX system offers individualized relief and has FDA approval for specific indications such as painful diabetic neuropathy (PDN) and non-surgical back pain (NSBP), aiming to deliver comprehensive, long-term pain relief.
### Metadata
| Field        | Value |
|--------------|-------|
| Name         | Nevro |
| Slug         | nevro |
| URL          | https://optimly.ai/brand/nevro |
| Logo         | https://logo.clearbit.com/nevro.com |
| Brand Authority Index tier | Low Visibility |
| Archetype    | Incumbent |
| Category     | Medical Devices |
| Last Analyzed | August 9, 2026 |
| Last Updated | 2026-08-10T16:15:58.146Z |
### Buyer Intent Signals
#### Problems this brand solves
- Traditional Pain Management: Utilizing pharmacological interventions (e.g., opioids, NSAIDs), physical therapy, occupational therapy, and cognitive-behavioral therapy for chronic pain.
- Living with Chronic Pain: Choosing not to pursue advanced interventional treatments, continuing to manage pain with existing methods or enduring chronic discomfort.
#### Buyers search for
- Nevro 10 kHz Therapy
- HFX spinal cord stimulation PDN
- Alternative SCS Systems: Using spinal cord stimulation systems from competitors such as Medtronic, Abbott, or Boston Scientific, which may offer different stimulation paradigms or features.
- Other Interventional Pain Procedures: Procedures like nerve blocks, radiofrequency ablation, or intrathecal drug delivery systems.
#### Buyers compare
- Alternatives to spinal cord stimulation for chronic pain
### Links
- Canonical page: https://optimly.ai/brand/nevro
- Publisher: https://optimly.ai
- Dataset: https://optimly.ai/brand
- JSON endpoint: /brand/nevro.json
- LLMs.txt: /brand/nevro/llms.txt